Insiders · Profile

GOLDSTEIN DOV A MD

Chief Financial Officer at BioAge Labs · Director at Coya Therapeutics. Filing since 3 Jan 2023. CIK 0001120478

Company
Date
Role
Action
Shares
Amount
Of holding
13 Jan 2026
Chief Financial Officer
Sold on a plan
27,000
$531.83K
54.6%
3 Jan 2023
Director
Bought
10,000
no price
opened
2 decisions on file.